sb 203580 has been researched along with chromium in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (chromium) | Trials (chromium) | Recent Studies (post-2010) (chromium) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 16,673 | 285 | 7,207 |
| 3,489 | 4 | 1,137 | 3,378 | 6 | 2,524 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakeman, TP; Wyczechowska, D; Xu, B | 1 |
| Wang, YQ; Yao, MH | 1 |
2 other study(ies) available for sb 203580 and chromium
| Article | Year |
|---|---|
Involvement of the p38 MAP kinase in Cr(VI)-induced growth arrest and apoptosis.
Topics: Apoptosis; Carcinogens, Environmental; Cell Cycle; Cell Proliferation; Cell Survival; Chromium; Dose-Response Relationship, Drug; Enzyme Inhibitors; HeLa Cells; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Pyridines | 2005 |
Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Chromium; Enzyme Activation; Glucose; Glucose Transporter Type 4; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Resistance; Mice; p38 Mitogen-Activated Protein Kinases; Picolinic Acids; Protein Transport; Pyridines; Signal Transduction | 2009 |